Welcome to Scholar Publishing Group

International Journal of World Medicine, 2024, 5(1); doi: 10.38007/IJWM.2024.050106.

Advances in Pharmacological Mechanism of Eucommia Ulmoides in Treating Parkinson's Disease


Chaofan Li, Yanni Liu

Corresponding Author:
Yanni Liu

Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, 712000, Shaanxi, China


Parkinson's disease is a common clinical neurodegenerative disease, mainly manifested by motor retardation, quiescence tremor, myotonia, etc., which seriously affects patients' physical and mental health and quality of life.Eucommia ulmoides is a commonly used traditional Chinese medicine for Parkinson's disease, which has the effect of tonifying liver and kidney, strengthening muscles and bones.Through the analysis of several drug components, animal and in vitro cell experiments, and the in-depth exploration of network pharmacology, it was found that Eucommia ulmoides contained a variety of effective active ingredients, such as peach-leaf corallin, eucommia ulmoides polysaccharide, protocatechuic acid, chlorogenic acid, caffeic acid, geniposide, etc.It can be used to treat Parkinson's disease by anti-neuroinflammation, anti-oxidative stress, inhibition of apoptosis and enhancement of nerve autophagy.In this paper, the active components of Eucommia ulmoides and their effects on receptor proteins and signaling pathways were summarized, so as to clarify the pharmacological mechanism of Eucommia ulmoides in the treatment of Parkinson's disease and provide reference for future research directions of Eucommia ulmoides in the treatment of Parkinson's disease.


Parkinson's Disease, Eucommia Ulmoides, Mechanism of Action, Research Progress

Cite This Paper

Chaofan Li, Yanni Liu. Advances in Pharmacological Mechanism of Eucommia Ulmoides in Treating Parkinson's Disease. International Journal of World Medicine (2024), Vol. 5, Issue 1: 48-58. https://doi.org/10.38007/IJWM.2024.050106.


[1] Chinese Society of Parkinson′s Disease and Movement Disorders, Parkinson′s Disease and Movement Disorder Section of Neurologist Branch of Chinese Medical Doctor Association. Chinese guidelines for theTreatment of Parkinson′s disease (fourth edition). Chinese Iournal of Neurology, 2020,53(12):973-986.

[2] Zhang Z, Roman G C, Hong Z, et al. Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai. The Lancet, 2005,365(9459):595-597.

[3] Li G, Ma J, Cui S, et al. Parkinson′s disease in China: a forty‐year growing track of bedside work. Transl Neurodegener, 2019, 8: 22. DOI: 10.1186/s40035‐019‐0162‐z.

[4] Zhang Sen, Zhao Xiaoyue, Liang Yu, et al. Advances in understanding the pathogenic factors and pathogenesis of Parkinson’s disease. Acta Pharmaceutica Sinica, 2020,55(10):2264-2272.

[5] Li Lin, Zhang Rui, Suo Xiaoyan, et al. Clinical effect of levodopa combined with pramipexole in the treatment of Parkinson's disease and its influence on UPDRS score of patients. Clinical Research and Practice, 2021,6(21):80-82.

[6] Wei Yufan, Zhang Yunke, Fan Feiyan, et al. Meta Analysis and Data Mining of Chinese Medicine Compounds in the Treatment of Sleep Disorders in Parkinson’s Disease. Acta Chinese Medicine, 2022,37(1):216-226.

[7] Bao Qian, Zhao Yawei, Huo Xiaoxiao, et al. Research progress of traditional Chinese medicine for Parkinson′s disease treatment. Modern Journal of Integrated Traditional Chinese and Western Medicine, 2019,28(30):3416-3420.

[8] Yang P, Zhang Q, Shen H, et al. Research progress on the protective effects of aucubin in neurological diseases. Pharmaceutical Biology, 2022,60(1):1088-1094.

[9] Ji Xiaomin. Exploring the Mechanism of Yougui Pill's "Seeking Yang from Yin" Promoting Neural Regeneration in EAE Mice through Neurodirectional Factors[D]. Capital Medical University, 2016.

[10] Jing Lei, Ma Yunzhi. Summary of Professor Ma Yunzhi's Experience in Treating Middle and Late Stage Parkinson's Disease. Guangming Journal of Chinese Medicine, 2018,33(19):2813-2815.

[11] Yang Kai, Zou Jiuli, Ji Yongxiang. Clinical effect observation of Tianma Gouteng decoction in the treatment of Parkinson's disease. Clinical Research and Practice, 2017,2(9):97-98.

[12] Dou Weihua, Diao Limei. Clinical study of Bushen Huoxue decoction in the treatment of Parkinson disease. Journal of Changchun University of Chinese Medicine, 2010,26(4):501-502.

[13] Li Lili, Ma Ningning, Fan Shanshan, et al. Therapeutic effects and spectra-effect relationship of different extracts of Eucommia ulmoides on Parkinson's disease mice. Chinese Traditional and Herbal Drugs, 2019,50(6):1400-1406.

[14] Zhang Pengyu, Jin Meng, Shang Xueliang, et al. Study on anti-Parkinson′s disease activity of Eucommia ulmoides based on network pharmacology and zebrafish model. Chinese Pharmacological Bulletin, 2022,38(7):1081-1087.

[15] Gao, X., et al., Neuroprotective effect of chlorogenic acid on Parkinson's disease like symptoms through boosting the autophagy in zebrafish. European Journal of Pharmacology, 2023. 956: p. 175950.

[16] Ning Gang, Wu Hui, Li Bonan, et al. Hepatocyte growth factor being the possible material basis for"homogeny of Yi and Gui". Journal of Hunan University of Chinese Medicine,2022,42(10): 1720-1724.

[17] Cao Bingqian. TAN Feng’s Experience in Treating Early Parkinson’s Disease Based on the Pathogenesis of Kidney Deficiency with Marrow Hollow and Internal Stirring of Liver Wind. Journal of Guangzhou University of Traditional Chinese Medicine,2022,39(8):1906-1910.

[18] Chen Shi-ya, Xiao Shao-jian, Lin You-ning, et al. Clinical Efficacy and Transcriptomic Analysis of Congrong Shujing Granules in Patients with Parkinson’s Disease and Syndrome of Shen (Kidney) Essence Deficiency. Chinese Journal of Integrative Medicine, 2020,26(6):412-419.

[19] Jin Z, Liu Z, Kang L, et al. A randomized double-blind placebo-controlled multicenter trial of Bushen Yisui and Ziyin Jiangzhuo formula for constipation in Parkinson disease. Medicine, 2020,99(28):e21145.

[20] Zhang L, Yang H. Promotive effects of tetrahydroxystilbene glucoside on the differentiation of neural stem cells from the mesencephalon into dopaminergic neurons. Neuroscience Letters, 2021,742:135520.

[21] Dong H, Zhang J, Rong H, et al. Paeoniflorin and Plycyrrhetinic Acid Synergistically Alleviate MPP+ /MPTP-Induced Oxidative Stress through Nrf2-Dependent Glutathione Biosynthesis Mechanisms. ACS Chemical Neuroscience, 2021,12(7):1100-1111.

[22] Chinese Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China: Volume 1, 2020 [S]. Beijing:China Medical Science Press,2020.

[23]Gao Hongwei, Li Yuping, Li Shouchao. Study Advances in Chemical Constituents and Pharmacological Effects of Eucommia Ulmoides Oliv.Information on Traditional Chinese Medicine,2021,38(06):73-81.DOI:10.19656/j.cnki.1002-2406.210615.

[24] Trist, B.G., D.J. Hare and K.L. Double, Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease. Aging Cell, 2019. 18(6): p. e13031.

[25] Li Y C, Hao J C, Shang B, et al. Neuroprotective effects of aucubin on hydrogen peroxide-induced toxicity in human neuroblastoma SH-SY5Y cells via the Nrf2/HO-1 pathway. Phytomedicine, 2021,87:153577.

[26] Xue H, Jin L, Jin L, et al. Aucubin prevents loss of hippocampal neurons and regulates antioxidative activity in diabetic encephalopathy rats. Phytotherapy Research, 2009,23(7):980-986.

[27] Hink U, Li H, Mollnau H, et al. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res, 2001,88(2):E14-E22.

[28] Sun Xixiao, Liu Zaizhi, Du Xinqi, et al. Ultrasonic-assisted Extraction of Polysaccharide from Eucommia ulmoides and Evaluation of its Antioxidant Activity. Bulletin of Botanical Research, 2014,34(3):428-432.

[29] Yin Xue, Su Xinyun, Wang Xiuhua, et al. Effects of protocatechuic acid on expression of D2DR, iNOS, and TH in striatum and midbrain of Parkinson's disease model mice. Chinese Traditional and Herbal Drugs, 2015,46(06):866-870.

[30] Oboh G, Agunloye O M, Akinyemi A J, et al. Comparative Study on the Inhibitory Effect of Caffeic and Chlorogenic Acids on Key Enzymes Linked to Alzheimer’s Disease and Some Pro-oxidant Induced Oxidative Stress in Rats’ Brain-In Vitro. Neurochemical Research, 2013,38(2):413-419.

[31] Jeayeng S, Wongkajornsilp A, Slominski A T, et al. Nrf2 in keratinocytes modulates UVB-induced DNA damage and apoptosis in melanocytes through MAPK signaling. Free Radical Biology and Medicine, 2017,108:918-928.

[32] Qu Z, Sun J, Zhang W, et al. Transcription factor NRF2 as a promising therapeutic target for Alzheimer’s disease. Free Radical Biology and Medicine, 2020,159:87-102.

[33] Huang, T., et al., The therapeutic effect of aucubin-supplemented hyaluronic acid on interleukin-1beta-stimulated human articular chondrocytes. Phytomedicine, 2019. 53: p. 1-8.

[34] Buelna-Chontal M, Zazueta C. Redox activation of Nrf2 & NF-κB: A double end sword?. Cellular Signalling, 2013,25(12):2548-2557.

[35] Qiu Y, Cheng X, Bai F, et al. Aucubin protects against lipopolysaccharide-induced acute pulmonary injury through regulating Nrf2 and AMPK pathways. Biomedicine & Pharmacotherapy, 2018,106:192-199.

[36] de Oliveira M R, de Bittencourt Brasil F, Fürstenau C R. Sulforaphane Promotes Mitochondrial Protection in SH-SY5Y Cells Exposed to Hydrogen Peroxide by an Nrf2-Dependent Mechanism. Molecular Neurobiology, 2018,55(6):4777-4787.

[37] Bao S, Lin J, Xie M, et al. Simvastatin affects Nrf2/MAPK signaling pathway and hepatic histological structure change in Gambusia affinis. Chemosphere, 2021,269:128725.

[38] Lefaki M, Papaevgeniou N, Tur J A, et al. The dietary triterpenoid 18α–Glycyrrhetinic acid protects from MMC-induced genotoxicity through the ERK/Nrf2 pathway. Redox Biology, 2020,28:101317.

[39] Li Z, Wang Q, Luan H, et al. A novel target TAX1BP1 and P38/Nrf2 pathway independently involved in the anti-neuroinflammatory effect of isobavachalcone. Free Radical Biology and Medicine, 2020,153:132-139.

[40] Lu Y H, Su M Y, Huang H Y, et al. Protective effects of the citrus flavanones to PC12 cells against cytotoxicity induced by hydrogen peroxide. Neurosci Lett, 2010,484(1):6-11.